MSB 7.24% $1.19 mesoblast limited

Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-62

  1. 129 Posts.
    lightbulb Created with Sketch. 69
    Will simply add weight to ALL other current platforms especially ARDS & GvHD when it comes to arguing the case with FDA (F...ing Deluded Americans)...

    Strong re emphasis of timing in the treatment being paramount.

    When u put this against all other results (sans endpoint / FDA decision) the direction is clear.

    Been a ride and a half...GLTA!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.